IOPROMIDE PARENTERAL LIQUID MINIMUM 300 MG IODINE/ML BOX X VIAL(S)/BOTTLE(S) X 50 ML

This tender concerns the procurement of Iopromide parenteral liquid, a contrast agent used in medical imaging. The specific requirement is for a formulation containing a minimum of 300 mg of iodine per milliliter, supplied in packaging consisting of vials or bottles, each containing 50 ml. The contracting entity is the CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES, DIALISIS LA MARISCAL. The procurement process is being conducted through an Electronic Reverse Auction (Subasta Inversa Electrónica), identified by the process code SIE-CMFIEDM-2025-081-748941. A total quantity of 1000 units is required, with an estimated value of USD 21,140.00. This tender is relevant for pharmaceutical suppliers specializing in medical contrast media. The electronic reverse auction format suggests a competitive bidding process where suppliers will be able to submit progressively lower bids to secure the contract. Interested parties should review the detailed specifications and bidding instructions provided by the CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES, DIALISIS LA MARISCAL to ensure compliance with all technical and procedural requirements. The focus on a specific iodine concentration and volume per container indicates a need for precise product specifications.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 21,140.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.